IQVIA Holdings | IQV - Operating Profit


IQVIA Holdings reported $565M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Accenture USD 3.18B 681.75M Mar/2026
Agilent USD 399M 46M Mar/2026
Bruker USD 10.2M 66.1M Mar/2026
Cardinal Health USD 861M 98M Mar/2026
Celltrion KRW 13.72B 287.31B Dec/2025
Charles River Laboratories USD 119.9M 44.08M Mar/2026
Cigna USD 2.76B 204M Mar/2026
Cognizant Technology Solutions USD 843M 10M Mar/2026
Computer Programs Systems USD -119.41M 121.35M Dec/2025
Cspc Pharmaceutical CNY 206.26M 1.02B Dec/2025
CVS Health USD 4.68B 2.57B Mar/2026
Danaher USD 1.34B 158M Mar/2026
Dentsply International USD 32M 506M Mar/2026
Deva Holding AS TRY 964.87M 240.32M Sep/2023
Dianthus Therapeutics USD -69.54M 29.25M Dec/2025
Divis Laboratories Ltd INR 8.14B 420M Mar/2026
Elevance Health USD -5.81B 6.39B Mar/2026
Humana USD 1.75B 2.56B Mar/2026
IBM USD 4.25B 1.7B Dec/2025
Illumina USD 239M 17M Mar/2026
Infosys INR 84.09B 83.02B Dec/2025
Kangmei Pharma CNY -10.94M 15.75M Mar/2026
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Laboratorios Farma EUR 135.05M 49.84M Dec/2023
Laboratory Of America USD 410.1M 28.1M Mar/2026
Malin Corporation EUR -1.1M 400K Dec/2024
McKesson USD 1.84B 181M Mar/2026
Mettler Toledo International USD 233.93M 118M Mar/2026
Organigram Holdings CAD -20.13M 7.92M Dec/2025
Ovoca Bio EUR -1.16M 4.48M Jun/2025
Pharma Mar EUR 622K 42.99M Mar/2026
Publicis EUR 1.39B 189M Dec/2025
Qiagen NV USD 121.88M 15.41M Dec/2025
Quest Diagnostics USD 399M 13M Mar/2026
Revvity USD 82.77M 63.06M Mar/2026
Sartorius EUR 160.7M 9.5M Mar/2026
Sino Biopharmaceutical CNY 5.18B 3.32B Jun/2025
Thermo Fisher Scientific USD 1.91B 389M Mar/2026
Tilray USD -20.01M 9.34M Sep/2025
UnitedHealth USD 9.04B 5.78B Mar/2026
Veeva Systems USD 273.11M 27.24M Mar/2026
Veradigm USD -45.47M 70.47M Dec/2022
Waters USD 148M 122.52M Mar/2026
Zealand Pharma A/S -707.05M 245.73M Dec/2025
Zz Pientze Pharmaceu CNY 837.81M 336.48M Mar/2026